Article ID Journal Published Year Pages File Type
5866451 American Journal of Infection Control 2016 7 Pages PDF
Abstract

•High BMIs' impact on death, infectious outcomes was first valued by meta-analysis.•This paper revealed that high BMIs did not predict high 30-day mortality after gastrointestinal surgery.•In this paper, we found that high BMIs were associated with more pulmonary infections.•We confirmed that high BMIs could increase risks of infectious outcomes and surgical site infections.

BackgroundThe influence of high body mass index (BMI) on mortality and infectious outcomes of patients following open gastrointestinal surgery was unclear. This meta-analysis aimed to resolve this controversy.MethodsPubMed and EMBASE were searched by 2 researchers. High and normal BMIs were defined as ≥25 and 18.5-24.99, respectively. Odds ratios (ORs) were calculated to compare the pooled effect sizes. The primary outcome was mortality. The secondary outcome was infectious outcomes, including surgical site, pulmonary infections, and urinary tract infections.ResultsEleven eligible articles with 51,307 patients total were included. Compared with normal BMIs, high BMIs did not increase the risk of mortality (OR, 0.78; 95% confidence interval [CI], 0.58-1.06; P = .12). The secondary outcome indicated a significantly higher risk of infectious outcomes in high-BMI patients (OR, 1.34; 95% CI; 1.13-1.58; P = .0007). Among high-BMI patients, the risks of surgical site infections (OR, 1.75; 95% CI, 1.33-2.3; P < .0001) and pulmonary infections (OR, 1.2; 95% CI, 1.02-1.40; P = .03) increased significantly; urinary tract infections (OR, 1.10; 95% CI, 0.92-1.31; P = .30) did not show statistical difference.ConclusionsHigh BMI was associated with higher risks of infectious outcomes, including surgical site infections and pulmonary infections after open gastrointestinal surgery, but no association was observed between high BMI and urinary tract infections.

Related Topics
Life Sciences Immunology and Microbiology Microbiology
Authors
, , , , ,